![](/img/cover-not-exists.png)
PD-069 Quality-of-Life (COL) assessment in two docetaxel dose-schedulesas second-line treatment of advanced non small cell lung cancer (NSCLC): Spanish Lung Cancer Group (SLCG) Phase III trial
Camps, C., Massuti, B., Jiménez, A., Maestu, I., Garcia, R., Isla, M., González-Larriba, J., Almenar, D., Carrato, A., Rosell, R.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80402-7
Date:
July, 2005
File:
PDF, 277 KB
english, 2005